Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.25.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Operating activities    
Net income (loss) $ 1,906 $ (12,571)
Income from discontinued operations, net of tax 6,483 160
Net loss from continuing operations (4,577) (12,731)
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Depreciation expense 2,724 2,923
Amortization expense 459 522
Amortization of debt issuance costs 217 74
Asset impairments 1,622 0
Deferred income taxes (32) 6,639
(Reduction of) provision for losses on accounts receivable (488) 214
Non-cash lease expense 85 96
Stock-based compensation expense 512 592
Changes in operating assets and liabilities:    
Accounts receivable and advances (5,210) (246)
Inventories (1,450) 3,692
Other assets and liabilities (1,517) (708)
Accounts payable (1,535) (2,621)
Accrued expenses 1,741 1,809
Accrued income taxes (119) 669
Net cash (used in) provided by operating activities - continuing operations (7,568) 924
Net cash provided by operating activities - discontinued operations 6,783 4,934
Net cash (used in) provided by operating activities (785) 5,858
Investing activities    
Purchases of property, plant and equipment (1,082) (737)
Net cash used in investing activities - continuing operations (1,082) (737)
Net cash provided by investing activities - discontinued operations 52,525 2,253
Net cash provided by investing activities 51,443 1,516
Financing activities    
Borrowings from credit facilities 114,470 156,923
Proceeds from note payable 1,085 914
Payments on credit facilities (114,470) (156,923)
Payments on note payable (696) (633)
Principal payments on finance lease obligations (219) (219)
Repurchase of common stock (8,875) (738)
Net cash used in financing activities - continuing operations (8,705) (676)
Net cash used in financing activities - discontinued operations (19) (2)
Net cash used in financing activities (8,724) (678)
Increase in cash and cash equivalents 41,934 6,696
Less: Cash and cash equivalents of discontinued operations 0 10
Cash and cash equivalents at beginning of period 16,108 1,841
Cash and cash equivalents at end of period 58,042 8,547
Supplemental Disclosure of Cash Flow Information    
Interest 148 207
Noncash Investing Activities:    
Capital expenditures, not yet paid $ 149 $ 107